| scholarly article | Q13442814 |
| P50 | author | John J Friedewald | Q42686679 |
| Sunil M Kurian | Q46181458 | ||
| Daniel R. Salomon | Q112670906 | ||
| P2093 | author name string | J Miller | |
| L Gallon | |||
| Y S Kanwar | |||
| J Levitsky | |||
| M M Abecassis | |||
| A R Tambur | |||
| J R Leventhal | |||
| J Charette | |||
| C Jie | |||
| J M Mathew | |||
| I Konieczna | |||
| P2860 | cites work | Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 |
| Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms | Q33195020 | ||
| HLA-mismatched renal transplantation without maintenance immunosuppression | Q33640791 | ||
| Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays | Q33867234 | ||
| Identification of a B cell signature associated with renal transplant tolerance in humans. | Q33882845 | ||
| Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture | Q34446000 | ||
| Mixed Chimerism, Lymphocyte Recovery, and Evidence for Early Donor-Specific Unresponsiveness in Patients Receiving Combined Kidney and Bone Marrow Transplantation to Induce Tolerance | Q34691385 | ||
| Tolerance associated gene expression following allogeneic hematopoietic cell transplantation | Q35182401 | ||
| Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation | Q35216479 | ||
| Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation | Q35898871 | ||
| Depletion of foxp3(+) T cells abrogates tolerance of skin and heart allografts in murine mixed chimeras without the loss of mixed chimerism | Q35911438 | ||
| Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants | Q35918706 | ||
| Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance | Q36024233 | ||
| Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome | Q36492262 | ||
| Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation | Q36722979 | ||
| Genomic biomarkers correlate with HLA-identical renal transplant tolerance | Q37119938 | ||
| Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens | Q37149887 | ||
| Calcineurin inhibitors in HLA-identical living related donor kidney transplantation | Q37464226 | ||
| Tolerance and chimerism after renal and hematopoietic-cell transplantation | Q40428891 | ||
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine | Q42028666 | ||
| The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. | Q42954783 | ||
| T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients | Q46081831 | ||
| Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation | Q46084204 | ||
| Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. | Q53557826 | ||
| Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses | Q73383278 | ||
| Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses | Q73383293 | ||
| Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation | Q74494006 | ||
| In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens | Q77859052 | ||
| Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism | Q78237930 | ||
| FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion | Q80521452 | ||
| Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation | Q86763876 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 221-234 | |
| P577 | publication date | 2015-07-30 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers | |
| P478 | volume | 16 |
| Q54216691 | A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants. |
| Q53475944 | A composite score associated with spontaneous operational tolerance in kidney transplant recipients. |
| Q57143685 | Biomarkers and Pharmacogenomics in Kidney Transplantation |
| Q33842783 | Biomarkers in renal transplantation: An updated review |
| Q37462039 | Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment? |
| Q38754342 | Cell therapeutic approaches to immunosuppression after clinical kidney transplantation |
| Q39215677 | Chimerism-based tolerance in organ transplantation: preclinical and clinical studies. |
| Q50145136 | Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy |
| Q64982406 | Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. |
| Q48215037 | Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance |
| Q38935186 | Hematopoietic stem cells and solid organ transplantation |
| Q38793766 | Immune monitoring in renal transplantation: The search for biomarkers |
| Q45074422 | Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation. |
| Q55450034 | Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy. |
| Q42368320 | Rapamycin is highly effective in murine models of immune-mediated bone marrow failure |
| Q41444299 | Recent Progress in Cell Therapy in Solid Organ Transplantation |
| Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
| Q26751022 | Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms |
| Q50164418 | Updated Follow-Up of a Tolerance Protocol in HLA-identical Renal Transplant Pairs Given Donor Hematopoietic Stem Cells. |
| Q47822802 | Using omics to explore complications of kidney transplantation. |
Search more.